Recce’s unapproved drug proves successful treatment for life-threatening illness

  • Home
  • Company News
  • Recce’s unapproved drug proves successful treatment for life-threatening illness
07Apr

Recce’s unapproved drug proves successful treatment for life-threatening illness

 

Superbug and viral pathogen treatment developer Recce Pharmacetical (ASX:RCE)’s unapproved drug R327 has successfully saved a patient suffering a life-threatening illness.

Despite not undertaking clinical trials, nasal treatment R327 was accessible to the individual via Category A of the Therapeutic Goods Administration special access scheme. Recce (ASX:RCE) intends to proceed with clinical trials for the product.

The news has shot Recce’s shares up 5.1 per cent to $1.03
Copyright 2021 – Finance News Network


Source: Finance News Network

Share this post

Related Posts

11Sep

ACCC will not oppose AIRR rural deal with Elders

12 Sep 2019 - The ACCC will not oppose the proposed acquisition of rural wholesale buying group Australian Independent Rural Retailers by Elders (ASX:ELD).

Read More
16Apr

Stocks of the Hour: Dalaroo Metals, Decmil Group, Far Northern Resources

16 Apr 2024 - A snapshot of the stocks on the move, featuring Dalaroo Metals (ASX:DAL), Decmil Group (ASX:DCG) and Far Northern Resources (ASX:FNR).

Read More
21Feb

OceanaGold (ASX:OGC) reports a loss of US$150.4 million

19 Feb 2021 - OceanaGold (ASX:OGC) has a reported a loss of US$150.4 million compared to a $14.5 million profit a year ago.

Read More
05Apr

Stocks of the Hour: Linius Technologies, Biotron, Elixir Energy

05 Apr 2024 - A snapshot of the stocks on the move, featuring Linius Technologies Ltd (ASX:LNU), Biotron Limited (ASX:BIT) and Elixir Energy (ASX:EXR).

Read More
03Aug

Infigen Energy (ASX:IFN) revenue drops despite production rise

03 Aug 2020 - Infigen Energy (ASX:IFN) has seen a 26 per cent drop in revenue in the fourth quarter (Q4), even though the company reported increased production. The company blamed the impact of Covid-19 which severely impacted electricity prices.

Read More
09Jul

Worley (ASX:WOR) increases stake in TW Power Services

09 Jul 2020 - Worley (ASX:WOR) has acquired Ferrovial’s 50 per cent shareholding of TW Power Services for a cash consideration of $20 million, increasing its stake to 100 per cent.

Read More
15Apr

Bubs Australia (ASX:BUB) reports positive operating cashflow

15 Apr 2020 - Baby formula brand Bubs Australia (ASX:BUB) have reported a positive operating cashflow of $2.3 million on sales of $23.4 million for the first 2020 quarter ending March 31, 2020.

Read More
01Jul

Stocks of the Hour: Westpac, Worley, Seek & Lendlease

01 Jul 2021 - A snapshot of the news that broke today featuring Westpac (ASX:WBC), Worley (ASX:WOR), Seek (ASX:SEK) and Lendlease (ASX:LLC).

Read More
26Feb

Reece (ASX:REH) EBITDA up 12% in HY21

26 Feb 2021 - Plumbing and bathroom supplies company Reece (ASX:REH) achieved 3.07 billion in sales revenue in the half-year ended 31 December 2020.

Read More
23Mar

Flight Centre (ASX:FLT) cancels $40.1 million dividend payment

23 Mar 2020 - Flight Centre (ASX:FLT) announced today that to lower costs from the coronavirus impact - their senior leadership team will take a 50 per cent salary cut.

Read More